Odor identification and mortality in old age

Chemical Senses

Volumn 36, Issue 1, 2011, Pages 63-67

  Wilson, Robert S ^a,b   Yu, Lei ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Longitudinal studies; Mortality; Odor identification

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; AGING; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SMELLING; SMELLING DISORDER;

EID: 78650397603     PISSN: 0379864X     EISSN: 14643553     Source Type: Journal    
DOI: 10.1093/chemse/bjq098     Document Type: Article

References (38)

1. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon CF, Bienias JL, Wilson RS. 2005. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 25:163-175.
2. Braak H, del Tredici K, Rub U, de Vos RAI, Jansen Steur ENH, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 24:197-211.
3. Calhoun-Haney R, Murphy C. 2005. Apolipoprotein e4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores. Brain Cogn. 58:178-182.
4. Cox DR. 1972. Regression models and life tables (with discussion). J R Stat Soc Series B. 74:187-220.
5. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R. 2000. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 157:1399-1405.
6. Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, Andrews H, Brown TR, DeCarli C, Mayeux R. 2010. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging. 31:1593-1600.
7. Doty RL, Frye RE, Agrawal U. 1989. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys. 45:381-384.
8. Doty RL, Marcus A, Lee WW. 1996. Development of the 12-item Cross Culture Smell Identification Test (CC-SIT). Laryngoscope. 106(3, Pt 1):353-356.
9. Doty RL, Reyes PF, Gregor T. 1987. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 18:597-600.
10. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorksi L, Rosenbert L. 1984. Smell identification ability: changes with age. Science. 226: 1441-1443.
11. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB. 1999. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E e4 status. Neurology. 53:1480-1487.
12. Hawkes CH, Shephard BC, Daniel SE. 1997. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatr. 62:436-446.
13. Hubbard PS, Esiri MM, Reading M, McShane R, Nagy Z. 2007. Alphasynuclein pathology in the olfactory pathways of dementia patients. J Anat. 211:117-124.
14. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. 1963. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 185:914-923.
15. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. 1993. Two shorter forms of the CES-D depression symptoms index. J Aging Health. 5:179-193.
16. Larsson M, Finkel D, Pedersen NL. 2000. Odor identification: influences of age, gender, cognition, and personality. J Gerontol Psychol Sci. 55B: P304-P310.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA work group under the auspices of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:939-944.
18. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. 1989. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1159-1165.
19. Murphy C, Bacon AW, Bondi MW, Salmon DP. 1998. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci. 855:744-750.
20. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. 1990. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging. 11:465-469.
21. Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R. 2005. Anosmia is a very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatr. 76:1342-1347.
22. Ponsen MM, Stoffers D, Booji J, van Eck-Smit BL, Wolters ECh, Berendse HW. 2004. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 56:173-181.
23. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, et al. 2006. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 21: 2062-2067.
24. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR. 2008. Association of olfactory dysfunction with future Parkinson's disease. Ann Neurol. 63:167-173.
25. Russell MJ, Cummings BJ, Profitt BF, Wysocki CJ, Gilbert AN, Cotman CW. 1993. Life span changes in the verbal categorization of odors. J Gerontol Psychol Sci. 48:P49-P53.
26. Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ. 1996. Longitudinal changes in smell identification. J Gerontol Med Sci. 51A:M86-M91.
27. Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A. 2010 Jul 28. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Mov Disord. doi: 10.1002/mds.23234.
28. Swan GE, Carmelli D. 2002. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology. 21:58-67.
29. Wang QS, Tian L, Huang YL, Qin S, He LQ, Zhou JN. 2002. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Res. 951:77-81.
30. Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. 2009. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatr. 80:667-670.
31. Wilson RS, Arnold SE, Beck TL, Bienias JL, Bennett DA. 2008. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry. 65:439-446.
32. Wilson RS, Arnold SE, Buchman AS, Tang Y, Bennett DA. 2008. Odor identification and progression of parkinsonian signs in older persons. Exp Aging Res. 34:173-187.
33. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. 2009. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 1170:730-735.
34. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. 2007. The relationship between cerebral Alzheimer's disease pathology and odor identification in old age. J Neurol Neurosurg Psychiatr. 78:30-35.
35. Wilson RS, Arnold SE, Tang Y, Bennett DA. 2006. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 26:61-67.
36. Wilson RS, Beck TL, Bienias JL, Bennett DA. 2007. Terminal cognitive decline: accelerated loss of cognition in the last years of life. Psychosom Med. 69:131-137.
37. Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. 2007. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 69:1911-1920.
38. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. 2007. Olfactory identification and incidence of mild cognitive impairment in old age. Arch Gen Psychiatry. 64:802-808.